Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children
- PMID: 20019130
- DOI: 10.1530/EJE-09-1033
Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children
Abstract
Background and aims: Ghrelin is an orexigenic 28-amino acid peptide produced by the stomach. Circulating ghrelin levels rise shortly before and fall shortly after every meal. Peptide YY (PYY), an anorexigenic 36-amino acid peptide, is secreted primarily from the intestinal mucosa of the ileum and large intestine. Plasma PYY levels begin to rise within 15 min after starting to eat and plateau within approximately 90 min, remaining elevated for up to 6 h. Recently, some studies have tried to evaluate the potential role of ghrelin and PYY in the hyperphagia of patients with Prader-Willi syndrome (PWS). While hyperghrelinemia is well characterized in PWS, conflicting results have been reported for PYY. The aim of the study was to investigate ghrelin and PYY responses to a standard liquid high-fat meal in children with PWS.
Patients and methods: Circulating levels of total ghrelin and PYY levels were assayed by RIA after overnight fasting and 45, 60, 90, and 180 min following a standard meal (Ensure 6 ml/kg) in 16 patients with PWS (11 boys and five girls, aged 4.6-10.7 years, including ten receiving 0.02 mg/kg per day rhGH for 2-18 months; body mass index (BMI) z-score: 0.6+/-0.2 and 1.6+/-0.5 for children treated or not treated with rhGH respectively), ten obese (eight boys and two girls, aged 9.2-15.6 years; BMI z-score: 2.4+/-0.2, i.e. BMI >97th centile for chronological age and sex) subjects, and 16 normal-weight controls (five boys and 11 girls, aged 5.8-17.3 years; BMI z-score: 0.6+/-0.2).
Results: PWS children showed higher fasting levels of ghrelin than obese and lean controls. Postprandial ghrelin drop was more pronounced in PWS than in the other study groups. No significant difference on fasting levels of PYY was found among groups. PWS showed a higher postprandial PYY rise than obese and lean controls. PWS patients treated and not treated with GH showed similar fasting and postprandial levels of ghrelin and PYY. Fasting PYY levels correlated negatively (P<0.05; r=-0.68) with those of ghrelin only in PWS.
Conclusions: The results of this study confirm fasting hyperghrelinemia in PWS. Since in PWS adults an impaired postprandial suppression of plasma ghrelin was previously reported to be associated with a blunted postprandial PYY response, the finding of a meal-induced decrease and increase in ghrelin and PYY levels respectively in PWS children would imply that the regulation of appetite/satiety of these peptides is operative during childhood, and it progressively deteriorates and vanishes in adulthood when hyperphagia and obesity worsen.
Similar articles
-
Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.J Clin Endocrinol Metab. 2015 Oct;100(10):3822-31. doi: 10.1210/jc.2015-2503. Epub 2015 Aug 10. J Clin Endocrinol Metab. 2015. PMID: 26259133 Free PMC article. Clinical Trial.
-
In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.Neuropeptides. 2011 Aug;45(4):301-7. doi: 10.1016/j.npep.2011.06.001. Epub 2011 Jul 1. Neuropeptides. 2011. PMID: 21722955
-
Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.Horm Metab Res. 2004 Mar;36(3):164-9. doi: 10.1055/s-2004-814340. Horm Metab Res. 2004. PMID: 15057669
-
Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.Endocrine. 2012 Apr;41(2):191-9. doi: 10.1007/s12020-011-9560-4. Epub 2011 Nov 12. Endocrine. 2012. PMID: 22081257 Review.
-
Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.Obes Rev. 2020 May;21(5):e12992. doi: 10.1111/obr.12992. Epub 2019 Dec 30. Obes Rev. 2020. PMID: 31889409 Review.
Cited by
-
Prader-Willi syndrome: reflections on seminal studies and future therapies.Open Biol. 2020 Sep;10(9):200195. doi: 10.1098/rsob.200195. Epub 2020 Sep 23. Open Biol. 2020. PMID: 32961075 Free PMC article. Review.
-
Nutritional phases in Prader-Willi syndrome.Am J Med Genet A. 2011 May;155A(5):1040-9. doi: 10.1002/ajmg.a.33951. Epub 2011 Apr 4. Am J Med Genet A. 2011. PMID: 21465655 Free PMC article.
-
Changes in levels of peripheral hormones controlling appetite are inconsistent with hyperphagia in leptin-deficient subjects.Endocrine. 2014 Apr;45(3):401-8. doi: 10.1007/s12020-013-0009-9. Epub 2013 Jul 4. Endocrine. 2014. PMID: 23824601
-
Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review.Front Endocrinol (Lausanne). 2025 Jan 21;15:1528457. doi: 10.3389/fendo.2024.1528457. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39906041 Free PMC article. Review.
-
Hedonic eating in Prader-Willi syndrome is associated with blunted PYY secretion.Food Nutr Res. 2017 May 2;61(1):1297553. doi: 10.1080/16546628.2017.1297553. eCollection 2017. Food Nutr Res. 2017. PMID: 28659728 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical